Albuminag dry is a drug from the group of plasma replacement solutions based on albumin.
International nonproprietary name - Albuminag.
Albuminag dry is used to replenish the volume of circulating blood in case of hypovolemia of various origins, including injuries, burns, blood loss, and dehydration.
The drug contains human albumin, which increases the oncotic pressure of blood plasma, improves microcirculation and oxygen delivery to tissues.
Albuminag dry is well tolerated and practically does not cause allergic reactions. It is administered intravenously after dissolution in distilled water.